Synovial sarcoma is not common in the head and neck region. Because its histopathologic features are many and varied, it is often misdiagnosed. We report a case of biphasic synovial sarcoma of the pos terior pharyngeal wall, and \Ve discuss the clinical and patho logic features ofthis case.
Introduction
Synovial sa rco ma is a rare malign an t tumor that der ives from a mesench ymal precursor ste m ce ll that is unrelated to mature synovia l tissue. Its be havior in the head and neck regio n is simi lar to that of a synovial sarcoma that invo lves the extremities, where the tumor is mos t common. We report a case of a biphasic synovial sarco ma of the posterior pha ryngeal wa ll.
Case report
A 54-year-old man was referred to the ENT Department by the Departm ent ofGastroentero logy. He had comp lained of progressively worsen ing dysp hag ia and symptoms ofacid reflux. He reported no other sym pto ms relat ing to the ea r, nose, and throat, and he had no histo ry of a loss of weight or appetite. He had given up smok ing 30 years earlier.
Exam ination revealed the presence of a ped unculated mu cosal lesion on the posterior pharyngeal wa ll; the mass was situated to the left of the midline and just above the piriform fossa . No cerv ical lym phadenopathy was pa lpable. Findings on the rem ainder of the ENT exam inat ion were normal. A lateral neck x-ray demo nstrated an abnorma l protrusion of soft tissue fro m the posterior pharyngeal wa ll at the level of C3 (figure I).
T he pat ient underwent a pharyngoscopy, and the mass was removed as an excisiona l biopsy under general anesthesia . Histo logic exa mi natio n revealed that the tumor was made up offibrob last -like spindle ce lls, amo ng which ep ithe lium-like ce lls were arranged in variab le patterns of so lid nests, interconnected cords , g landu lar formations, and cleft-like spaces (fig ure 2 ). Most of the spi nd le ce lls and a lesser proport ion ofthe epithe lial ce lls were reactive for the mesenchym al marker vime ntin ( figure 3 ) . The ep ithelia l markers cytokeratin, CAM 5.2, and epithe lial mem brane antige n (EMA) highl igh ted the de licate str uctures of the epi thelia l component ( figure 4 ). The excision ofthe lesion was dee med incom plete. The pat ient subseq uent ly underwent a partial phary ngectom y wit h rad ial forear m flap reco nstr uction and preservation of the lary nx. He made a complete recovery and was disc ha rged home I wee k postoperatively. He was followed monthly at our mult idisciplin ary head and neck cl inic, and at 12 mon ths, he rem ained free of rec urre nce.
Discussion
Sy nov ial sarcoma is an aggressive tumor that origi nates in the mesenchyma l tiss ue. Des pite its name , it rare ly arises fro m mature sy nov ial tissue. Tumors of the head and neck account for 3 to 10% of all synovial sarcomas. I Jern strom publ ished the first reported case of a synovial sarcoma of the head and neck (hypophary nx) in 1954. 2 Since then, synovial sarcomas have been reported at ot her sites in the head and neck , incl ud ing the nasoph aryn x, retroph arynx, hypopharynx, laryngopharyn x, para pharyngea l space, and esophagus.':" Synov ial sarcoma classically affec ts patients between the ages of 15 and 40 years,' ? and the proportion of ma le-to-female patie nts is 3:2,9
Our patient presente d wit h nonspec ific swallowi ng symptoms, which highl ight s the importa nce ofa complete clin ica l eva luatio n of any patie nt who presents with such vague symptoms . No appreciable difference has been repor ted in the biologic act ivity of a synov ial sarcoma in the head and neck and a sy novial sa rco ma at any other site, I but rep orts on survival data are co nflict ing. Pai et al report ed that surv iva l in cases of neck disease was higher than that in cases of limb tum ors." O n the other hand , Kar tha and Bumpo us found that the 5-year surv ival rate for patients wi th head and neck sy novia l sa rco ma was 40% , which is substantia lly lower tha n the 60% 5-year survival rate rep orted in the literature for sy novial sarco ma at a ll othe r sites ."
Histologi call y, three variants of sy novia l sarco ma have been describ ed : biphasic, monoph asic fibro us, and monophasic ep ithelial.The class ic fea tures include spindle ce lls and interposed epithe lial e leme nts wi th a delicate cleft-like glandu lar pattern highl igh ted by cytokeratin immun oh istochem istry. Th e spindle ce ll co mponent stro ng ly ex presses vime nti n, while the epit he lial eleme nt is posit ive for cytokeratin, CA M 5.2, and EMA, whi ch are hallmarks of biph asic synov ial sa rco ma .
Preoperatively, co mputed tom ograph y and magnetic resona nce imag ing are the inves tiga tions of choice to determin e the location and extent of the tumor.
Prim ary surg ica l excision is the mai nstay of treatm ent ; radiotherapy is rese rve d for residu al or recu rren t disease." Postoperative radiothera py is sai d to decrease the likelihood ofloca l recu rrence, but it has not imp roved long-t erm survival.II The ro le of chemothera py is controversial," altho ugh Lenoir et ai l 2 repo rted a dram atic regression in tumor size in a IS-m onth-old patient wit h a retro pharyngea l synovial sa rco ma after treatm en t wi th a comb inati on of ifosfam ide, vinc ristine, and ac tino mycin D. The future ro le of bot h radiothera py and che mo thera py in the management of synov ial sarcoma need s to be determin ed by a prospective study.
Favorable progn ostic ind icators include an ear ly diag-nosis, sma ll tumo r size « 5 em), yo unge r age «20 yr), and a wide surg ica l excision.l-" :" Of these, tumo r size is the sing le most important prog nos tic determ inant , as tum ors of 10 em in diam eter or larger are associated with a poor progn osis. " Amble et al reported a se ries of 14 pati ent s w ho had been treated for sy nov ial sarcoma of the head and neck over a 30-year period, and they found that recurrent or metastatic tumors arose between 4 and 62 month s after the development of the origina l tum or." Th eir find ings emphas ize the need for long-term fo llow -up. Wright et al found that me tas tases tend to be bloodborne in most cases, w ith 10 to 20% of patient s ex periencing lym ph nod e metastasis. '? Acco rding to Na dig et aI, lung metastasis accounts for more than 90% of all metastases.' Because head and neck synovial sa rco ma in clinical pra cti ce is so uncommon , early diagn osis is d ifficult and the treatm ent pro toco l is uncl ear. Th erefore, every case report should include complete information on present ation and management. Also, long-term prognostic indic es need to be eva luated.
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Continued fro m page 297 nonsurgically sta yed an avera ge of 7.6 days, and their mean bill was $8 ,241. Stro ng et al co mpared arterial ligation performed by an otolaryngo log ist wit h percutaneous embo liza tion performe d by a radio logi st." While the surgeons' fees and the interventional rad iologists' fees were simi lar, operating room costs were approximately ha lf as much as angiography suite costs.
Finally, the major complications associated with posterior packing often lead physic ians to admit patients to the intensi ve care unit, where costs can amount to thousands ofdollars per day.!' All these findings suggest that the early use of endoscopic ligation can be cost -effective .
Our recommendations correspond w ith those reported by other authors. Our experience dem on strates that early surg ical ligation of the sphenopalatine artery in coagulopathic patients who are at increased risk of persistent bleeding is cost-effective and is associated wit h less patient morbidity. We suggest that surgery should be preferentially considered as first-line management in such patients. It is a safe, successful, and economically advantageous method of mana gem ent in coagulopathic patients wit h posterior epistaxis.
